Van Eck Associates Corp Neogenomics Inc Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 1,360 shares of NEO stock, worth $19,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,360
Previous 1,724
21.11%
Holding current value
$19,162
Previous $23,000
4.35%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NEO
# of Institutions
296Shares Held
125MCall Options Held
698KPut Options Held
116K-
Black Rock Inc. New York, NY19.7MShares$277 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14MShares$198 Million0.0% of portfolio
-
Brown Advisory Inc6.89MShares$97.1 Million0.13% of portfolio
-
Janus Henderson Group PLC London, X06.6MShares$93 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.54MShares$92.2 Million0.06% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.77B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...